Delivery Order SPE2DB22D3501-SPE2DB25FVC73

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,272.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The order has an ultimate completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,718.62, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, with a ceiling value of $8,666.46. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.29, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,544.12, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 14, 2024. The contract is not designated as a set-aside and was awarded through open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,064.04, is for the delivery of 4,567,988,585 units of the pharmaceutical product FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product, with a ceiling value of $9,243.97 and a completion date of January 10, 2024. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,786.20, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract is a delivery order and is priced on a firm fixed-price basis. The contract has an ultimate completion date of December 27, 2024. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,187.75 and a period of performance through June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a $4,908.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, to support federal healthcare programs. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVC73
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,908.92, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract has an ultimate completion date of April 1, 2025 and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/30/25, 10:56 AM